Ladostigil
Ladostigil, also called as TV-3,326, is a novel neuroprotective agent developed to treat neurodegenerative disorders sunch as Alzheimer's disease. Ladostigil is a dual acetylcholine-butyrylcholineesterase and brain selective monoamine oxidase (MAO)-A and -B inhibitor in vivo (with little or no MAO inhibitory effect in the liver and small intestine).
| Supplier | BOC Sciences |
|---|---|
| Product # | 209394-27-4 |
| Pricing | Inquire |
| Cas | 209394-27-4 |
| Molecular Weight | 272.348 |
| Molecular Formula | C16H20N2O2 |
| Canonical SMILES | CCN(C)C(=O)OC1=CC2=C(CCC2NCC#C)C=C1 |